Results 91 to 100 of about 5,906 (249)

A patient-centred and multi-stakeholder co-designed observational prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphataemia (XLH)

open access: yesPLoS ONE
The importance of patient centricity and keeping the patient at the heart of research design is now well recognised within the healthcare community. The involvement of patient, caregiver and clinician representatives in the study design process may help ...
V. Saraff   +11 more
semanticscholar   +1 more source

Recurrent phosphaturic mesenchymal tumour of the temporal bone causing deafness and facial nerve palsy [PDF]

open access: yes, 2017
Objective: We describe the first reported case of a phosphaturic mesenchymal tumour, mixed connective tissue variant, invading the temporal bone. Case report: A female patient presented with increasing deafness. On examination there appeared to be a mass
Chatzimichalis, M.   +3 more
core  

Peri‐operative identification and management of patients with unhealthy alcohol intake

open access: yesAnaesthesia, Volume 80, Issue 3, Page 311-326, March 2025.
Summary Introduction This consensus statement gives practical advice for the safe management of patients with harmful alcohol intake undergoing elective and emergency surgery. The wide spectrum of alcohol‐related organ dysfunction observed in this cohort of patients may have a profound impact on care, and the additional effects of alcohol withdrawal ...
Matthew J. A. Jenkins   +10 more
wiley   +1 more source

Critical illness myopathy [PDF]

open access: yes, 2010
Critical illness myopathy (CIM) is a syndrome of widespread muscle weakness and neurological dysfunction which can develop in critically ill patients receiving intensive care.
Ali, Tazeen   +2 more
core   +2 more sources

Transient imaging changes accompany ‘spinal ICANS’ following CAR T‐cell therapy for large B‐cell lymphoma in adults

open access: yes
British Journal of Haematology, Volume 207, Issue 6, Page 2632-2637, December 2025.
Frederick W. Vonberg   +14 more
wiley   +1 more source

2024 update in heart failure

open access: yesESC Heart Failure, Volume 12, Issue 1, Page 8-42, February 2025.
Abstract In the last years, major progress has occurred in heart failure (HF) management. The 2023 ESC focused update of the 2021 HF guidelines introduced new key recommendations based on the results of the last years of science. First, two drugs, sodium–glucose co‐transporter‐2 (SGLT2) inhibitors and finerenone, a novel nonsteroidal, selective ...
Alberto Beghini   +12 more
wiley   +1 more source

Differences in adverse events between manuscript and drug labels for myeloma T‐cell‐redirecting therapies

open access: yes
British Journal of Haematology, Volume 207, Issue 4, Page 1659-1663, October 2025.
Bita Bashy   +5 more
wiley   +1 more source

Iron optimisation in pregnancy: a Haematology in Obstetric and Women's Health Collaborative consensus statement

open access: yesInternal Medicine Journal, Volume 55, Issue 2, Page 300-307, February 2025.
Abstract Anaemia is a well‐recognised and widely accepted consequence of iron deficiency (ID); however, the two diagnoses are not synonymous with the effects of ID occurring long before the development of anaemia. In adults, ID can cause physical and neuropsychological symptoms, including lethargy, altered mood and poor concentration, reducing an ...
Lisa Clarke   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy